In summary, our data indicate a protein-free pathway for the formation of RNA condensates that could be relevant for the initiation and/or progression of C9orf72 mutation-related ALS and FTD pathogenesis, making mG4s a potential therapeutic target for these devastating and currently incurable neurodegenerative diseases. Here, C9orf72 is linked to neurodegenerative disease.